AnaptysBio, Inc.
NASDAQ:ANAB
36.57 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -163.619 | -128.724 | -57.796 | -19.931 | -97.336 | -61.656 | -30.07 | -4.259 | -5.405 | 3.532 | -5.545 |
| Depreciation & Amortization
| 2.376 | 2.335 | 2.09 | 0.559 | 0.514 | 0.315 | 0.183 | 0.233 | 0.274 | 0.308 | 0.58 |
| Deferred Income Tax
| -10.938 | 0 | 0.478 | 0 | -2.633 | -1.233 | 1.377 | 0.757 | 1.28 | 0.062 | -0.621 |
| Stock Based Compensation
| 33.205 | 27.356 | 15.347 | 11.499 | 12.411 | 9.961 | 4.378 | 1.16 | 0.604 | 0.16 | 0.151 |
| Change In Working Capital
| -0.324 | 6.839 | -7.489 | -6.771 | 16.851 | 3.461 | 4.075 | -7.026 | -6.532 | 9.268 | -1.247 |
| Accounts Receivables
| -5.432 | -0.543 | -0.876 | 0 | 0.174 | 1.427 | 1.225 | 0.001 | 0.229 | -1.455 | 0.268 |
| Inventory
| 5.108 | 0 | 0 | 0 | -0.174 | 0 | -237.974 | -5.336 | 0.343 | -0.489 | 0.132 |
| Accounts Payables
| 10.938 | 9.7 | -4.74 | -8.877 | 14.499 | 7.083 | 2.218 | 1.251 | 1.949 | 0.482 | -0.255 |
| Other Working Capital
| -10.938 | -2.318 | -1.873 | 2.106 | 2.352 | -3.622 | 238.606 | -2.942 | -9.053 | 10.73 | -1.392 |
| Other Non Cash Items
| 18.5 | 18.601 | 1.45 | 0.487 | 0.676 | 0.646 | 0.619 | 0.105 | 0.11 | 1.273 | 0.886 |
| Operating Cash Flow
| -120.8 | -73.593 | -45.92 | -14.157 | -69.517 | -48.506 | -19.438 | -9.03 | -9.669 | 14.603 | -5.796 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -0.807 | -0.358 | -1.366 | -0.569 | -0.805 | -1.063 | -0.29 | -0.05 | -0.238 | -0.145 | -0.037 |
| Acquisitions Net
| -145.561 | 394.487 | 0.015 | 194.927 | 251.815 | 347.537 | 290.905 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -303.919 | -802.503 | -118.662 | -194.927 | -251.815 | -347.537 | -290.905 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 449.48 | 408.016 | 158.848 | 289.971 | 384.051 | 206.149 | 48.137 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 145.561 | -394.487 | 40.201 | -194.927 | -251.815 | -347.537 | -290.905 | 0 | 0 | 0.005 | 0 |
| Investing Cash Flow
| 144.754 | -394.845 | 38.835 | 94.475 | 131.431 | -142.451 | -243.058 | -0.05 | -0.238 | -0.14 | -0.037 |
| Financing Activities: | |||||||||||
| Debt Repayment
| -11.726 | -30.685 | -0.072 | -1.375 | -7.5 | -6.875 | 0 | -10 | 0 | -5 | 0 |
| Common Stock Issued
| 2.472 | 11.827 | 2.553 | 0.496 | 3.007 | 227.476 | 292.537 | 0.031 | 0.16 | 0 | 0.004 |
| Common Stock Repurchased
| -50 | 0 | 0 | 0 | 0 | 0 | 0 | -0.001 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 11.683 | 62.875 | 249.817 | -0.879 | -4.493 | 2.763 | -0.084 | 8.598 | 39.243 | 4.915 | 1.96 |
| Financing Cash Flow
| -59.297 | 44.017 | 252.298 | -0.879 | -4.493 | 223.364 | 292.453 | 8.628 | 39.403 | 4.915 | 1.964 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -35.343 | -424.421 | 245.213 | 79.439 | 57.421 | 32.407 | 29.957 | -0.452 | 29.496 | 19.378 | -3.869 |
| Cash At End Of Period
| 35.965 | 71.308 | 495.729 | 250.516 | 171.077 | 113.656 | 81.249 | 51.232 | 51.684 | 22.188 | 2.81 |